W. Brade
Impact in
-
- Chemotherapy-induced organ toxicity mitigation
-
- Cancer Treatment and Pharmacology
- Polyomavirus and related diseases
Papers in
-
- Renal and related cancers 5
- DNA Repair Mechanisms 3
- RNA Research and Splicing 2
- Oncology 9
- Drug Transport and Resistance Mechanisms 3
- Co-authors
- M. Varini (1 shared paper)H. Herken (5 shared papers)L.S. Hnilica (3 shared papers)S. Seeber (1 shared paper)P. Hilgard (1 shared paper)Jen‐Fu Chiu (4 shared papers)J.F. Chiu (1 shared paper)R. L. Nelson (1 shared paper)
- Journals
- Naunyn-Schmiedeberg s Archives of Pharmacology (5 papers)Journal of Cancer Research and Clinical Oncology (3 papers)Cancer Treatment Reviews (3 papers)Biochemical Pharmacology (2 papers)Journal of Molecular Medicine (2 papers)
- Partner nations
- GermanyUnited StatesAustria
In The Last Decade
W. Brade
38 papers receiving 653 citations
Peers
Comparison fields: 5 of 91
- Pathology and Forensic Medicine 200
- Oncology 185
- Pharmacology 46
- Hematology 46
- Cancer Research 50
Countries citing papers authored by W. Brade
This map shows the geographic impact of W. Brade's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by W. Brade with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites W. Brade more than expected).
Fields of papers citing papers by W. Brade
This network shows the impact of papers produced by W. Brade. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by W. Brade. The network helps show where W. Brade may publish in the future.
Co-authors
The 25 scholars most cited alongside W. Brade, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 39 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1985 | 215 | |
| 2 | 1986 | 40 | |
| 3 | 1975 | 31 | |
| 4 | 1974 | 31 | |
| 5 | 1991 | 30 | |
| 6 | 1983 | 30 | |
| 7 | 1981 | 30 | |
| 8 | Evaluation of the cytotoxic activity of diethylstilbestrol and its mono- and diphosphate towards prostatic carcinoma cells. | 1988 | 24 |
| 9 | 1969 | 23 | |
| 10 | Similar bioavailability of single-dose oral and intravenous mesna in the blood and urine of healthy human subjects. | 1998 | 23 |
| 11 | 1975 | 21 | |
| 12 | 1979 | 20 | |
| 13 | 1998 | 18 | |
| 14 | 1976 | 17 | |
| 15 | 1974 | 15 | |
| 16 | 1975 | 13 | |
| 17 | [Lesion and regeneration of renal tubule cells following administration of folic acid]. | 1969 | 13 |
| 18 | 1970 | 12 | |
| 19 | 1974 | 11 | |
| 20 | 1988 | 9 |
About W. Brade
W. Brade is a scholar working on Molecular Biology, Oncology, Pathology and Forensic Medicine, Clinical Biochemistry and Pulmonary and Respiratory Medicine, having authored 39 papers that have together received 702 indexed citations. Recurring topics across this work include Chemotherapy-induced organ toxicity mitigation (6 papers), Metabolism and Genetic Disorders (6 papers), Renal and related cancers (5 papers), Estrogen and related hormone effects (4 papers), Folate and B Vitamins Research (4 papers), DNA Repair Mechanisms (3 papers), Drug Transport and Resistance Mechanisms (3 papers) and RNA Research and Splicing (2 papers). The work is most often cited by research in Pathology and Forensic Medicine (200 citations), Oncology (185 citations), Pharmacology (46 citations), Hematology (46 citations) and Cancer Research (50 citations). W. Brade has collaborated with scholars based in Germany, United States and Austria. Frequent co-authors include M. Varini, H. Herken, L.S. Hnilica, S. Seeber, P. Hilgard, Jen‐Fu Chiu, J.F. Chiu, R. L. Nelson, Richard W. Dyke and H. J. Merker. Their work appears in journals such as Naunyn-Schmiedeberg s Archives of Pharmacology, Journal of Cancer Research and Clinical Oncology, Cancer Treatment Reviews, Biochemical Pharmacology and Journal of Molecular Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.